Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Dominic Black

UCL Life Learning Project Manager

Dominic Black

E: d.black@ucl.ac.uk

Dominic has been working with UCL since 2012 managing the project that implemented the UCLeXtend e-learning platform. This project is embarking on another phase to enhance the available content and functionality.

In August 2013 Dominic joined the UCL Life Learning Team under Professor Andrew Eder to help manage project activities and the process of strategic and implementation planning.